Clinical Trial to Evaluate the Efficacy and Safety of D064 and D701 Combination Therapy

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 108 participants.

Also called NCT05526703

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 108 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05526703
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT05526703. Randomized; double masking; primary purpose treatment. Start 2022-09-28 (actual); primary completion 2023-10 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Clinical Trial to Evaluate the Efficacy and Safety of D064 and D701 Combination Therapy
Condition
Essential Hypertension
Intervention (Drug)
D064, D701, placebo of D012
Intervention (Drug)
D012, placebo of D064, placebo of D701
Lead sponsor
Chong Kun Dang Pharmaceutical (class: industry)

Record details

Record id
cardio:ct-nct05526703
Content hash
287d26c0827a53eaa2d0ddf861178a478681c8308856f2baa6073c58faa54869